Indeed, in one study, cancer cell lines treated with TNFα activate IKKβ, a component of the IKK complex that interacts with and phosphorylates TSC1, resulting in TSC1 inhibition and mTORC1 activation [103]. Here, TSC1 is linked to cancer.